DEUTSCHE BANK AG\ - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$147,301
+938.1%
10,514
+666.9%
0.00%
Q2 2023$14,190
-85.5%
1,371
-87.8%
0.00%
Q1 2022$98,000
-18.3%
11,278
-10.0%
0.00%
Q4 2021$120,000
-40.3%
12,538
+5.3%
0.00%
Q3 2021$201,000
+6.9%
11,908
-3.0%
0.00%
Q2 2021$188,000
-27.1%
12,273
-7.4%
0.00%
Q1 2021$258,000
-16.5%
13,254
-22.7%
0.00%
Q4 2020$309,000
+22.6%
17,148
+30.9%
0.00%
Q3 2020$252,000
-20.5%
13,104
+7.7%
0.00%
Q2 2020$317,000
+166.4%
12,162
+83.5%
0.00%
Q1 2020$119,000
-51.2%
6,628
-10.1%
0.00%
Q4 2019$244,000
+76.8%
7,369
+26.2%
0.00%
Q3 2019$138,000
-58.6%
5,837
-37.2%
0.00%
Q2 2019$333,000
-1.5%
9,294
+1.1%
0.00%
Q1 2019$338,000
-49.7%
9,189
-41.1%
0.00%
Q4 2018$672,000
-68.5%
15,610
-65.4%
0.00%
-100.0%
Q3 2018$2,132,000
+77.4%
45,158
+86.9%
0.00%
Q2 2018$1,202,000
-18.4%
24,158
-18.5%
0.00%
-100.0%
Q1 2018$1,473,000
-21.9%
29,659
-41.5%
0.00%0.0%
Q4 2017$1,885,000
+265.3%
50,667
+209.4%
0.00%
Q3 2017$516,000
+279.4%
16,376
+116.6%
0.00%
Q2 2017$136,0007,5600.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q1 2022
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 789,297$39,275,00060.44%
Wildcat Capital Management, LLC 251,459$12,513,0009.57%
Consonance Capital Management LP 1,487,491$74,018,0004.77%
MENORA MIVTACHIM HOLDINGS LTD. 2,499,870$124,394,0003.53%
MEITAV INVESTMENT HOUSE LTD 509,355$29,967,0001.34%
DSAM Partners (London) Ltd 127,588$6,349,0001.28%
SHIKIAR ASSET MANAGEMENT INC 48,125$2,395,0001.00%
BANK HAPOALIM BM 67,125$3,340,0000.91%
HIGHLINE CAPITAL MANAGEMENT, L.P. 331,900$16,515,0000.55%
Clal Insurance Enterprises Holdings Ltd 310,000$15,426,0000.40%
View complete list of UROGEN PHARMA LTD shareholders